• Flanders Investment & Trade
  • Team Vesalius

Annie Van Broekhoven has more than 30 years’ experience in biotechnology, in particular contract R&D, process development and GMP production.

Annie Van Broekhoven


Managing Director
Mevrouw Courtmansstraat 9
2600 Antwerpen

She has founded and until 2016 was the CEO of Q-Biologicals NV, a CDMO company, currently part of the Eurofins group, dedicated to the development of manufacturing processes and cGMP production of biologicals. Prior to that she was Vice-President Biologicals at Innogenetics.

Currently, she is a board member of different companies and is managing director of CreaBioSupport, a consulting company dedicated to help life science companies with their process development and GMP production, and in their growth through internal development and partnerships. She is a professor emeritus at the University of Antwerp, where she gave a course on Industrial Biotechnology and Microbiology.

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?